TRCT
CRL icon

Tower Research Capital (TRC)’s Charles River Laboratories CRL Stock Holding History

Tower Research Capital (TRC)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Sell
938
-1,542
-62% -$286K ﹤0.01% 1787
2025
Q4 		$495K Buy
2,480
+1,419
+134% +$257K 0.01% 834
2025
Q3 		$166K Buy
1,061
+187
+21% +$29.7K ﹤0.01% 1617
2025
Q2 		$133K Sell
874
-1,870
-68% -$249K ﹤0.01% 2146
2025
Q1 		$413K Sell
2,744
-1,777
-39% -$298K 0.01% 943
2024
Q4 		$835K Sell
4,521
-3,709
-45% -$714K 0.02% 723
2024
Q3 		$1.62M Buy
8,230
+3,823
+87% +$794K 0.04% 347
2024
Q2 		$910K Buy
4,407
+2,497
+131% +$566K 0.02% 835
2024
Q1 		$518K Sell
1,910
-4,326
-69% -$1.03M 0.01% 847
2023
Q4 		$1.47M Buy
6,236
+2,632
+73% +$518K 0.02% 630
2023
Q3 		$706K Buy
3,604
+292
+9% +$59.9K 0.02% 693
2023
Q2 		$696K Buy
3,312
+2,172
+191% +$432K 0.02% 748
2023
Q1 		$230K Sell
1,140
-1,702
-60% -$386K 0.01% 1292
2022
Q4 		$619K Sell
2,842
-2,154
-43% -$470K 0.03% 585
2022
Q3 		$983K Sell
4,996
-3,264
-40% -$705K 0.02% 712
2022
Q2 		$1.77M Sell
8,260
-647
-7% -$158K 0.04% 415
2022
Q1 		$2.53M Buy
8,907
+3,483
+64% +$1.07M 0.02% 515
2021
Q4 		$2.04M Buy
5,424
+4,656
+606% +$1.81M 0.04% 403
2021
Q3 		$317K Buy
768
+16
+2% +$6.64K 0.01% 1343
2021
Q2 		$278K Sell
752
-2,746
-79% -$917K 0.01% 1668
2021
Q1 		$1.01M Sell
3,498
-2,958
-46% -$822K 0.02% 781
2020
Q4 		$1.61M Sell
6,456
-4,678
-42% -$1.11M 0.05% 295
2020
Q3 		$2.52M Sell
11,134
-4,439
-29% -$921K 0.03% 267
2020
Q2 		$2.72M Buy
15,573
+13,854
+806% +$2.21M 0.11% 152
2020
Q1 		$217K Buy
1,719
+415
+32% +$62.2K 0.01% 719
2019
Q4 		$199K Buy
1,304
+707
+118% +$97.9K 0.02% 583
2019
Q3 		$79K Sell
597
-4,677
-89% -$627K 0.01% 1492
2019
Q2 		$749K Buy
5,274
+3,129
+146% +$424K 0.05% 345
2019
Q1 		$312K Buy
2,145
+1,404
+189% +$184K 0.02% 907
2018
Q4 		$84K Sell
741
-4,377
-86% -$548K 0.01% 1029
2018
Q3 		$688K Buy
5,118
+2,541
+99% +$314K 0.05% 341
2018
Q2 		$290K Sell
2,577
-166
-6% -$17.9K 0.02% 883
2018
Q1 		$293K Buy
2,743
+1,689
+160% +$182K 0.03% 717
2017
Q4 		$115K Buy
1,054
+964
+1,071% +$105K 0.01% 815
2017
Q3 		$10K Buy
+90
New +$9.25K ﹤0.01% 3062
2017
Q2 		– Sell
-100
Closed -$9.21K – 2803
2017
Q1 		$9K Sell
100
-331
-77% -$28.1K ﹤0.01% 1836
2016
Q4 		$33K Sell
431
-1,741
-80% -$132K ﹤0.01% 1711
2016
Q3 		$181K Buy
+2,172
New +$182K 0.02% 531
2016
Q2 		– Sell
-1,148
Closed -$87K – 4492
2016
Q1 		$87K Buy
1,148
+1,098
+2,196% +$81.3K 0.01% 540
2015
Q4 		$4K Sell
50
-650
-93% -$46.9K ﹤0.01% 3168
2015
Q3 		$44K Buy
700
+36
+5% +$2.58K ﹤0.01% 1112
2015
Q2 		$47K Buy
+664
New +$49.1K ﹤0.01% 1409
2015
Q1 		– Sell
-6,681
Closed -$425K – 4462
2014
Q4 		$425K Buy
6,681
+6,378
+2,105% +$400K 0.04% 145
2014
Q3 		$18K Sell
303
-1,860
-86% -$106K ﹤0.01% 2376
2014
Q2 		$115K Buy
2,163
+1,821
+532% +$99.9K 0.01% 828
2014
Q1 		$21K Buy
342
+338
+8,450% +$19.7K ﹤0.01% 1819
2013
Q4 		$0 Sell
4
-2,502
-100% -$126K ﹤0.01% 4519
2013
Q3 		$116K Buy
2,506
+2,231
+811% +$102K 0.01% 1154
2013
Q2 		$11K Buy
+275
New +$11.8K ﹤0.01% 2256

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tower Research Capital (TRC)'s CRL Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Charles River Laboratories (CRL) stake by 62% in Q1 2026, selling an estimated $286K and leaving 938 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Tower Research Capital (TRC) first reported a position in CRL in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.72M in Q2 2020. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Tower Research Capital (TRC) held 938 shares of Charles River Laboratories worth $162K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,542 Charles River Laboratories shares in Q1 2026, an estimated $286K.
  • Charles River Laboratories made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1787 holding.
  • Tower Research Capital (TRC) first reported a position in Charles River Laboratories in Q2 2013 and has held it in 49 quarters since.
  • Tower Research Capital (TRC)'s Charles River Laboratories position peaked at $2.72M in Q2 2020.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.